March 4, 2020
Citing a need to strengthen the existing warning about the risk of neuropsychiatric events associated with the drug, the FDA is now requiring a boxed warning in the labeling of Merck’s (MRK +4.6%) asthma med Singulair (montelukast sodium) and generic versions of the leukotriene receptor antagonist.
The agency says the precise incidence of said events is unknown but there have been reports of serious cases. It is also requiring a new medication guide to be given to patients with each prescription.
The New Your Times
March 9, 2020
As the coronavirus gained a foothold in the United States this weekend, thousands of employees from Seattle to Silicon Valley were told to work from home. Public school districts in several states have shut down, universities are moving classes to online only, and even churches are limiting services or prayer meetings.
As the coronavirus spread to two-thirds of the states, Americans began to grasp the magnitude of the threat facing them. The weekend’s case tally ballooned, veering toward nearly 600 cases and close to 20 deaths.
March 6th 2020
Just a week ago, the first “community spread” of the new coronavirus (COVID-19) was detected in the United States: a woman in Northern California who hadn’t been exposed to anyone known to have the virus.
Before her diagnosis, people in the United States were only thought to be at risk for COVID-19 if they had recently traveled to a high-risk area abroad or been exposed to someone who was sick.
But the woman in California hadn’t traveled internationally, nor had she been in contact with anyone with the infection.
This suggests that person-to-person transmission may be more likely than we originally anticipated.
New York Times,
March 3th, 2020
With the Coronavirus continuing to spread to more countries on Tuesday and epidemics in Iran, Italy and South Korea showing no signs of slowing, governments worked to devise plans to combat the pathogen without causing widespread social disruption and economic upheaval.
January 22th 2020
A local congressman is fighting to lower prescription drugs for American families.
“My fear is that I won’t be able to afford it,” said Chris Burrows, diabetes patient.
For diabetics, like Burrows, a vial of insulin could mean life or death. But skyrocketing prices could impact who gets it and who doesn’t.
Burrows attended a roundtable discussion hosted by Congressman Dan Kildee on Tuesday to voice his concerns.
Jan 12th 2020
The prices of more than 500 prescription drugs has risen since Jan. 1. The average price hike is about 5 percent. Among the drug prices that have increased are Cotempla XR, Eliquis, Truvada, and Humira. Read on to learn more about these and what you should know as an educated consumer in today’s world.
December 23th, 2019
The administration is issuing a proposed rule, along with a proposed guidance for the drug industry, that will allow states, pharmacies, wholesalers and manufacturers to import prescription drugs if they meet conditions designed to ensure that the importation poses no additional risk to safety and will save consumers money.
December 19th, 2019
The proposal is still a long way from being finalized, and many expensive drugs, like insulin, would be excluded from state plans.The decision is an unusual one for a Republican administration. Progressives have long supported such a policy, but the pharmaceutical industry vehemently opposed drug imports by claiming they were unsafe. Food and Drug Administration commissioners had also opposed importing drugs intended for overseas use, citing safety issues.
December 18th, 2019,
The Trump administration is paving the way for Americans to buy lower-cost prescription medication imported from Canada, in another push to reduce drug prices.
The administration on Wednesday offered two proposals to loosen longstanding federal restrictions on importing foreign drugs. Health and Human Services Secretary Alex Azar described the effort as “one of the highest priorities we have in the administration.”
Copyright © 2020 | Healthy Living Links